Biotech
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 04/03/12 -- Immunovaccine Inc. (TSX VENTURE: IMV) announced new findings today at the 2012 American Association for Cancer Research (AACR) meeting, which show ...
FAIRFIELD, NJ: Best Practices for Master Data Management Integration to Be Presented ...
NEW YORK, NY and TONGHUA, CHINA: NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 04/03/12 -- Biopharm Asia, Inc. (PINKSHEETS: BFAR) announced a status update regarding restated financial results of 2008, 2009 and 2010. As the re ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/03/12 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF) is pleased to report that all 19 subjects have ...
TORONTO, ONTARIO: - New Data Presented at the 2012 Annual Meeting of the American Association for Cancer Research (AACR) - ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 04/03/12 -- Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced the completion of dosing for Cohort ...
ORCHARD PARK, NY: Significant Enhancements Reinforce Foundation of Popular Data-Driven Decision Making Platform for Healthcare Industry ...
TUSTIN, CA: Antibodies Modified Through Several Genetic Methods Have Improved Biological Activity ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 04/02/12 -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) (Theratechnologies) announced today that it will issue its financial results for the first quarter end ...
TUSTIN, CA: Data From Phase I Trial Evaluating Bavituximab Plus Carboplatin and Pemetrexed Indicate Encouraging Anti-Tumor Activity and a Positive Safety Profile; Data From Imaging Studies Show Potent Upregulatio ...
MONTREAL, QUEBEC: Data Supports Ongoing Clinical Combination Studies with EGFR inhibitors ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 04/02/12 -- Biotonix (2010) Inc. ("Biotonix") (TSX VENTURE: BTX) is pleased to announce it has completed the second and final tranche of its previously- ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/02/12 -- Med BioGene Inc. (TSX VENTURE: MBI) today announced that the annual meeting of MBI shareholders scheduled for, and convened on March 30, 20 ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 04/02/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced that treatment with eteplirsen met the primary efficacy endpoint ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 03/30/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced it will hold a conference call at 8:00 a.m. EDT (5:00 a.m. PDT) ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 03/30/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that detailed results are now publ ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 03/30/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced the US Food and Drug Administration (FDA) has granted Orphan Drug Designation fo ...
TUCSON, AZ: Development of Tests That Help Identify Patients Most Likely to Respond to Targeted Therapy Is a Key Step Toward the Personalization of Medicine ...
